2164
Pulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy.
 Pulmonary edema: Effect; 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy: Treatment; 24 hours: Treatment.Time_elapsed; 10 hours: Treatment.Time_elapsed; intravenous: Treatment.Route; subcutaneous: Treatment.Route; ritodrine: Treatment.Drug; terbutaline: Treatment.Drug; ritodrine: Combination.Drug; terbutaline: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Pulmonary edema: Effect; 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy: Treatment; 24 hours: Treatment.Time_elapsed; 10 hours: Treatment.Time_elapsed; intravenous: Treatment.Route; subcutaneous: Treatment.Route; ritodrine: Treatment.Drug; terbutaline: Treatment.Drug; ritodrine: Combination.Drug; terbutaline: Combination.Drug